Abstract
ObjectiveHyperglycemia is associated with albuminuria and renal glomerular endothelial dysfunction in patients with diabetic nephropathy. The mTOR and RhoA/ROCK signaling pathways are involved in glomerular filtration barrier (GFB) regulation, but their role in high glucose (HG)-induced GFB dysfunction in human renal glomerular endothelial cells (HRGECs) has not been investigated. This study aimed to investigate the mechanisms of HG-induced GFB dysfunction in vitro.Materials and methodsHRGECs were cultured in vitro and exposed to HG. The horseradish peroxidase–albumin leakage and transendothelial electrical resistance of the endothelial monolayer were measured after HG treatment with or without rapamycin preincubation. A fluorescence probe was used to study the distribution of F-actin reorganization. The phosphorylation levels of myosin light chain (MLC) and mTOR were measured via western blotting. RhoA activity was evaluated via GTPase activation assay. The effects of blocking mTOR or the RhoA/ROCK pathway on endothelial permeability and MLC phosphorylation under HG conditions were observed.ResultsHG exposure induced F-actin reorganization and increased MLC phosphorylation, leading to EC barrier disruption. This effect was attenuated by treatment with rapamycin or Y-27632. Phospho-MLC (pMLC) activation in HRGECs was mediated by RhoA/ROCK signaling. mTOR and RhoA/ROCK inhibition or knockdown attenuated pMLC activation, F-actin reorganization and barrier disruption that occurred in response to HG exposure.ConclusionsOur results revealed that HG stimulation upregulated RhoA expression and activity through an mTOR-dependent pathway, leading to MLC-mediated endothelial cell cytoskeleton rearrangement and glomerular endothelial barrier dysfunction.
Highlights
Chronic hyperglycemia is the leading cause of diabetic nephropathy [1], which is characterized by albuminuria in the early stage [2, 3]
Phospho-myosin light chain (MLC) activation in human renal glomerular endothelial cells (HRGECs) was mediated by RhoA/ROCK signaling. Mechanistic target of rapamycin (mTOR) and RhoA/ROCK inhibition or knockdown attenuated pMLC activation, F-actin reorganization and barrier disruption that occurred in response to high glucose (HG) exposure
In summary, our present study demonstrated that mTOR activation and the subsequent upregulation of the RhoA/ ROCK/p-MLC pathway are essential for the development of HG-induced hyperpermeability in HRGECs in vitro
Summary
Chronic hyperglycemia is the leading cause of diabetic nephropathy [1], which is characterized by albuminuria in the early stage [2, 3]. Changes in endothelial contractility lead to increased permeability, which is affected by the activity of actin and myosin [3, 7, 13]. Activation of the Rho A GTPases and the downstream Rho kinase (ROCK), induce myosin light chain (MLC) phosphorylation [12, 14], which plays a major role in maintaining endothelial cell barrier integrity [15]. MLC phosphorylation facilitates contraction of the F-actin cytoskeleton and the creation of intercellular gaps between endothelial cells, thereby increasing GFB permeability [7, 9, 13, 16]. RhoA/ROCK activation has been shown to be involved in the glomerular hyperfiltration of albumin and microvascular/retinal complications of hyperglycemia [11, 17]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.